Nexalin Technology (NXL) Retained Earnings (2021 - 2026)
Nexalin Technology (NXL) posted Retained Earnings of $98.7 million for Q2 2026, up 0.89% on a QoQ basis from $97.8 million in Q1 2026, and up 4.82% year-over-year from $94.2 million in Q2 2025.
Analysis
Nexalin Technology (NXL) Retained Earnings (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Retained Earnings for 6 years, with the latest figure at $98.7 million in Q2 2026.
- On a quarterly basis, Retained Earnings rose 4.82% year-over-year to $98.7 million in Q2 2026; TTM through Jun 2026 was $98.7 million, a 4.82% increase from a year earlier, with the FY2025 full-year figure at $96.6 million, up 9.38% from the prior year.
- Retained Earnings was $98.7 million for Q2 2026 at Nexalin Technology, up from $97.8 million in the prior quarter.
- The five-year high for Retained Earnings was $98.7 million in Q2 2026, with the low at $77.8 million in Q4 2022.
- Average Retained Earnings over 5 years is $86.2 million, with a median of $83.7 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings soared 210.09% in 2022, then gained 1.9% in 2023.
- Over 5 years, Retained Earnings stood at $77.8 million in 2022, then gained by 3.1% to $80.2 million in 2023, then increased by 10.06% to $88.3 million in 2024, then grew by 9.38% to $96.6 million in 2025, then climbed by 2.18% to $98.7 million in 2026.
- The last three Retained Earnings figures came in at $98.7 million (Q2 2026), $97.8 million (Q1 2026), and $96.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 98.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.70 Mn |
| Mar 31, 2026 | 97.83 Mn |
| Dec 31, 2025 | 96.60 Mn |
| Sep 30, 2025 | 95.24 Mn |
| Jun 30, 2025 | 94.16 Mn |
| Mar 31, 2025 | 88.95 Mn |
| Dec 31, 2024 | 88.31 Mn |
| Sep 30, 2024 | 86.76 Mn |
| Jun 30, 2024 | 80.71 Mn |
| Mar 31, 2024 | 80.40 Mn |
| Dec 31, 2023 | 80.24 Mn |
| Sep 30, 2023 | 79.49 Mn |
| Jun 30, 2023 | 77.91 Mn |
| Mar 31, 2023 | 77.82 Mn |
| Dec 31, 2022 | 77.82 Mn |
| Sep 30, 2022 | 78.01 Mn |
| Dec 31, 2021 | -70.69 Mn |